跳至主要内容
临床试验/CTRI/2023/02/050044
CTRI/2023/02/050044尚未招募2 期

Efficacy and Safety of IMPUTE ADT-1 in children with autism spectrum disorder aged 2-6 years: a randomized controlled trial

Impute inc0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Confirmed diagnosis of autism spectrum disorder as per Autism Diagnostic Observation Schedule Second Edition (ADOS-2)
  • Parents willing to comply with the treatment for 6-months and regular follow up

排除标准

  • Persons with uncontrolled epilepsy
  • Hearing or vision impairment

研究者

发起方
Impute inc

相似试验